ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1150

Advocacy 101: Engaging Rheumatology Fellows in Health Policy and Advocacy

Sarah Doaty1, Sharon L. Kolasinski2, William F. Harvey3, Adam Cooper4 and E. Blair Solow5, 1Rheumatology, UCLA, Los Angeles, CA, 2Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 3Rheumatology, Tufts Medical Center, Boston, MA, 4American College of Rheumatology, Atlanta, GA, 5Rheumatology, UT Southwestern Medical Center, Dallas, TX

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Advocacy, education and trainee

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Education - Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Healthcare delivery and health policies in the United States are evolving rapidly. Rheumatology fellowship programs lack formal curricular content to educate trainees about legislative and regulatory healthcare policies that will have a profound impact on the future of academic and community practices.

Methods: A web-based survey was sent via the American College of Rheumatology (ACR) Fellows in Training (FIT) listserve in June and July 2015. The survey queried fellows enrolled in U.S. rheumatology training programs about their knowledge of and participation in health policy and advocacy. Survey results guided the design of an educational session called Advocacy 101 for fellows and program directors in October 2015 in conjunction with the ACR Advocates for Arthritis fly-in. Curriculum included introduction to state and federal legislative and regulatory policies as well as education on how to be an effective advocate. Participants were asked to take educational content from the event and hold a teaching session at their home institution. Participants also shared their experiences at the 2015 ACR Annual Meeting FIT roundtable sessions and the 2016 ACR State of the Art meeting Advocacy Workshop. A second survey was sent to fellows in April 2016.

Results: Survey response rates increased from 19% to 39% between 2015 and 2016. The majority of respondents were in adult training programs with nearly half (46% in 2015, 47% in 2016) reporting plans for a career in academics. Forty percent (up from 35% in 2015) reported that they were aware of advocacy efforts through the ACR. The top reason (64%) for non-participation in health policy and advocacy efforts in 2015 was lack of knowledge on how to get involved. This decreased to 39% of respondents reporting the same barrier in 2016. Other barriers to participation in 2016 included lack of time and familiarity with the issues. Only 7% felt their participation would have no effect, down from 16% the previous year. The health policy issues that 2016 participants identified as most important were patient access to medication (83%), patient access to insurance (68%) and physician reimbursement (58%). Fellows preferred in-person teaching sessions and online modules to email correspondence for education on these topics. The percentage of individuals who were familiar with and contributed to RheumPAC increased.

Conclusion: Engagement in health policy and advocacy efforts is critical to continued recruitment of trainees into the field of rheumatology, support for education and research, and advancement of clinical practice. Current training program curricula do not prepare fellows for the new challenges of our changing health care system. Advocacy 101 is the first program designed to educate and engage rheumatology fellows in health policy and advocacy endeavors. Fellows express an interest in becoming involved but view their lack of time and knowledge of the issues as their biggest barriers. Fellows indicate that ACR-sponsored events and formal curricula would be an effective way to gain knowledge on health policy and advocacy. Advocacy 101 is the first step in addressing this need.


Disclosure: S. Doaty, None; S. L. Kolasinski, None; W. F. Harvey, None; A. Cooper, None; E. B. Solow, None.

To cite this abstract in AMA style:

Doaty S, Kolasinski SL, Harvey WF, Cooper A, Solow EB. Advocacy 101: Engaging Rheumatology Fellows in Health Policy and Advocacy [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/advocacy-101-engaging-rheumatology-fellows-in-health-policy-and-advocacy/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/advocacy-101-engaging-rheumatology-fellows-in-health-policy-and-advocacy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology